BioNTech SE (BNTX)

161.08
+2.49(+1.57%)
  • Volume:
    246,708
  • Day's Range:
    158.60 - 161.60
  • 52 wk Range:
    117.08 - 390.00

BNTX Comments

What is your sentiment on BioNTech?
or
Vote to see community's results!

All Comments

(1888)
  • why us it tanking
    0
    • nice let's break th 20 dollars down mark
      1
      • people are getting severely crushed not only with bntx with almost everything
        1
        • looks like 150
          1
          • I dont think so
            0
          • Alper Drnlooks like 150
            0
        • holy I went from disgust that I sold on Friday to I don't get the 15 dollar turn the wrong way
          0
          • can someone elaborate on why bntx is up today nicely while moderna and nocanax are significantly negative
            0
            • Maybe because they are optimistic about Biontech earnings / financial reports for Monday (8 August)  Especially when they saw Moderna's good earnings.
              0
          • ok looks like bntx could be worth holding for a little bit how do you feel about the three vaccine stocks
            0
            • crazy I got in and got out four days ago along with moderna novanax was a big loss
              0
              • here is why it is tanking because I bought 25 shares I am the kiss of death
                0
                • It looks like the world is about to dive further into turmoil with a new wave of covid coupled with recession and panic
                  0
                  • I think the vaccine stocks could be the only way to go
                    0
                    • No direction yet
                      0
                      • 🚀🔆Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose.
                        3
                        • Covid is done, just like this stock. No movea will occur Until they produce something from their pipeline
                          10
                          • Coming soon I believe..
                            1
                        • 🚀 Great entry point for Therapeutics ready to release from the huge pipeline!
                          2
                          • covid globe it is best isn't it?
                            3
                            • 🚀 BioNTech submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of a 10-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred to as children ages 5 through <12).The submission included data from the Phase 2/3 clinical trial in children ages 5 through 11 years who received a booster dose approximately 6 months after the second dose of the Pfizer-BioNTech COVID-19 Vaccine 10-µg two-dose primary series, which was authorized under EUA for this age group in October 2021. Data from this study demonstrated a strong immune response in this age group following a booster dose of the Pfizer-BioNTech COVID-19 Vaccine with no new safety signals.
                              2
                              • BNTX will announce its financial results for the first quarter 2022 on Monday, May 9th, 2022. BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on the same day at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the first quarter 2022.
                                0
                                • New variants will keep BNTX consistently developing, keeping the public guarded, and deriving steady revenue upsurges...
                                  1
                                  • rrrrright.....
                                    0
                                    • Bellow 100$ in summer
                                      6
                                      • sure sure... take that pill and RIP!
                                        0
                                      • now, it seems that you made an excellent guess
                                        0
                                    • Rob Roo, you told everyone to buy when it was 350. Pathetic.
                                      3
                                      • You're a big boy, you can make your own decisions...
                                        2
                                    • Buy this temporary dip!!!
                                      1
                                      • BNTX announced positive results from a Phase 2/3 clinical trial evaluating the safety, tolerability and immunogenicity of a 10-µg booster (third) dose of the Pfizer-BioNTech COVID-19 vaccine in healthy children 5 through 11 years of age. These data demonstrate an increase in SARS-CoV-2 Omicron variant and wild-type strain neutralizing titers following a booster dose of the Pfizer-BioNTech COVID-19 vaccine compared to two doses. These data reinforce the potential function of a third dose of the vaccine in maintaining high levels of protection against the virus in this age group.
                                        1
                                        • 🔆🚀Pfizer and BioNTec Pfizer and BioNTech plan to submit a request for Emergency Use Authorization (EUA) of a booster dose for children ages 5 through 11 in the U.S. in the coming days. The companies also plan to share these data with the European Medicines Agency (EMA) and other regulatory agencies around the world as soon as possible.
                                          1